Spain’s Tucuvi raises €17 million to scale medical-grade voice AI
Spanish HealthTech startup Tucuvi has secured a €17 million funding round to accelerate the deployment of its medical-grade voice assistant, LOLA, across Europe. The company reports that its technology can automate up to 80% of nursing follow-up interactions, addressing one of the most pressing challenges in modern healthcare: chronic staff shortages and rising patient loads.
What Tucuvi and LOLA actually do
Tucuvi has developed LOLA, a conversational voice-based system designed specifically for remote patient monitoring and clinical follow-up. Unlike generic voice assistants, LOLA is built around validated clinical protocols and is integrated with hospital and clinic workflows.
Automating routine nursing calls
Using natural-language voice AI, LOLA calls patients on their regular phone lines, conducts structured health check-ins, and records clinically relevant information. The system can:
- Ask protocol-based questions about symptoms, medication adherence, and wellbeing
- Detect warning signs that require human intervention
- Flag high-risk cases to clinical teams in real time
- Document interactions directly into electronic health records or hospital systems
According to the company, this approach enables up to 80% automation of routine nursing follow-up tasks, freeing nurses to focus on complex cases, in-person care, and acute interventions.
Designed for elderly and chronic patients
The system is particularly targeted at elderly, frail, and chronic patients who require continuous monitoring after hospital discharge or during long-term treatment. By using standard phone calls rather than smartphone apps, LOLA aims to remove digital barriers for patients who are less comfortable with technology.
Why this funding round matters for European healthcare
European healthcare systems are under sustained pressure from an ageing population, rising rates of chronic disease, and persistent nursing shortages. Hospitals are seeking scalable ways to extend care beyond the hospital walls while maintaining clinical quality and safety.
Voice AI is emerging as a powerful tool in this context. Unlike text-based chatbots or app-driven monitoring, voice interactions mirror traditional phone-based nursing calls, which remain the standard for many post-discharge and chronic-care workflows. By automating these calls, Tucuvi is positioning LOLA as an infrastructure layer for virtual wards and hospital-at-home models.
Scaling across hospitals and health systems
The new €17 million injection will be used to:
- Expand LOLA‘s deployment across hospitals and primary care networks in Spain and other EU markets
- Enhance AI algorithms for symptom detection, risk stratification, and clinical triage
- Strengthen integrations with existing electronic medical record platforms
- Support regulatory and quality certifications in additional European jurisdictions
By consolidating its presence in Europe, Tucuvi aims to become a reference player in AI-powered remote care and automated follow-up for hospitals and insurers.
Clinical safety, regulation, and trust
Unlike consumer-focused AI tools, healthcare voice systems must operate under strict medical device and data protection regulations. Tucuvi positions LOLA as a medical-grade solution, emphasizing:
- Use of standardized and validated clinical pathways
- Audit trails for every patient interaction
- Compliance with GDPR and health data security requirements
- Close collaboration with clinicians to refine questions and triggers
For hospitals and health systems, trust in AI-driven automation hinges on safety, transparency, and measurable outcomes. Tucuvi is expected to use part of the new funding to deepen its evidence base, including clinical studies on reduced readmissions, improved adherence, and time saved for nursing teams.
The broader HealthTech and voice AI landscape
The funding round underscores a broader trend in European HealthTech: the shift from pilot projects to large-scale, integrated digital health infrastructure. As payers and providers move toward value-based care models, tools that can demonstrably reduce costs while maintaining or improving outcomes are gaining traction.
Voice AI sits at the intersection of accessibility and automation. It requires no new hardware for patients, works with landlines, and can be deployed rapidly across large populations. For overburdened health systems, this makes solutions like LOLA particularly attractive compared to more complex remote monitoring setups that depend on dedicated devices or apps.
Competition and differentiation
Globally, several startups are exploring AI-driven patient engagement, but Tucuvi differentiates itself through its focus on:
- Purely voice-based interactions compatible with any phone
- Deep integration into existing nursing and hospital workflows
- Automation levels high enough to materially reduce staff workload
- European-first, regulation-aware product development
This combination positions the company well as hospitals seek to modernize without overburdening clinical staff with new interfaces or complex training.
What comes next for Tucuvi and European care models
With fresh capital and growing demand for scalable remote patient monitoring solutions, Tucuvi is likely to broaden LOLA‘s use cases beyond post-discharge follow-up. Potential expansion areas include:
- Long-term management of chronic conditions such as heart failure, COPD, and diabetes
- Support for oncology patients between treatments
- Pre-surgical and post-surgical check-ins
- Population-level screening and outreach programs
As European health systems continue to experiment with virtual care and home-based treatment models, the ability to reliably automate large volumes of patient contact will be critical. The €17 million round marks a significant step for Tucuvi, and highlights how targeted AI technologies are beginning to reshape frontline healthcare operations, starting with the most time-consuming but essential task: keeping in close, continuous contact with patients.